Gaurav Shukla
Papers
1
Total Citations
3
H-Index
1
About
Gaurav Shukla is a clinical researcher whose work focuses on optimizing treatment sequencing and outcomes in head and neck oncology, particularly for HPV-positive oropharyngeal squamous cell carcinoma (OPSCC). His major contributions center on the critical timing between surgery and adjuvant radiation therapy (RT), a factor that directly influences patient prognosis. In his multi-institutional cohort study published in 2024, Shukla demonstrated that delays in starting RT after surgery—beyond the recommended six-week window—may compromise survival outcomes, providing evidence-based guidance for clinical decision-making. This work has already garnered 3 citations, reflecting its early impact on refining multimodality treatment protocols. By addressing the real-world challenges of care coordination in cancer management, Shukla’s research helps bridge the gap between clinical guidelines and practical implementation. His findings are particularly significant for HPV+ OPSCC patients, where treatment de-escalation strategies are increasingly explored. Through his rigorous analysis of large, multi-institutional datasets, Shukla contributes to the growing body of evidence that aims to personalize and improve the therapeutic timeline, ultimately enhancing survival and quality of life for head and neck cancer patients.
Research Focus
Key Achievements
Top Papers
- 1